84 related articles for article (PubMed ID: 26423570)
1. Biomarkers of aging, life span and spontaneous carcinogenesis in the wild type and HER-2 transgenic FVB/N female mice.
Panchenko AV; Popovich IG; Trashkov AP; Egormin PA; Yurova MN; Tyndyk ML; Gubareva EA; Artyukin IN; Vasiliev AG; Khaitsev NV; Zabezhinski MA; Anisimov VN
Biogerontology; 2016 Apr; 17(2):317-24. PubMed ID: 26423570
[TBL] [Abstract][Full Text] [Related]
2. Body weight is not always a good predictor of longevity in mice.
Anisimov VN; Arbeev KG; Popovich IG; Zabezhinksi MA; Rosenfeld SV; Piskunova TS; Arbeeva LS; Semenchenko AV; Yashin AI
Exp Gerontol; 2004 Mar; 39(3):305-19. PubMed ID: 15036390
[TBL] [Abstract][Full Text] [Related]
3. HER-2/neu is a tumor rejection target in tolerized HER-2/neu transgenic mice.
Reilly RT; Gottlieb MB; Ercolini AM; Machiels JP; Kane CE; Okoye FI; Muller WJ; Dixon KH; Jaffee EM
Cancer Res; 2000 Jul; 60(13):3569-76. PubMed ID: 10910070
[TBL] [Abstract][Full Text] [Related]
4. [Effect of antidiabetic drug diabenol on parameters of biological age, life span and tumor development in NMRI and HER-2/neu mice].
Popovich IG; Zabezhinskiĭ MA; Egormin PA; Anikin IV; Tyndyk ML; Semenchenko AV; Spasov AA; Anisimov VN
Adv Gerontol; 2004; 15():80-90. PubMed ID: 15754958
[TBL] [Abstract][Full Text] [Related]
5. [The effect of mithochondria targeted antioxidant SkQ1 on aging, life span and spontaneous carcinogenesis in three mice strains].
Iurova MH; Zabezhinskiĭ MA; Piskunova TS; Tyndyk ML; Popovich IG; anisimov VN
Adv Gerontol; 2010; 23(3):430-41. PubMed ID: 21137217
[TBL] [Abstract][Full Text] [Related]
6. Genetic modulation of neu proto-oncogene-induced mammary tumorigenesis.
Rowse GJ; Ritland SR; Gendler SJ
Cancer Res; 1998 Jun; 58(12):2675-9. PubMed ID: 9635596
[TBL] [Abstract][Full Text] [Related]
7. Vaccination of fiber-modified adenovirus-transfected dendritic cells to express HER-2/neu stimulates efficient HER-2/neu-specific humoral and CTL responses and reduces breast carcinogenesis in transgenic mice.
Sas S; Chan T; Sami A; El-Gayed A; Xiang J
Cancer Gene Ther; 2008 Oct; 15(10):655-66. PubMed ID: 18421311
[TBL] [Abstract][Full Text] [Related]
8. Effect of metformin on life span and on the development of spontaneous mammary tumors in HER-2/neu transgenic mice.
Anisimov VN; Berstein LM; Egormin PA; Piskunova TS; Popovich IG; Zabezhinski MA; Kovalenko IG; Poroshina TE; Semenchenko AV; Provinciali M; Re F; Franceschi C
Exp Gerontol; 2005; 40(8-9):685-93. PubMed ID: 16125352
[TBL] [Abstract][Full Text] [Related]
9. [Effect of light deprivation on homeostasis, life span and development of spontaneous tumors in HER-2/neu transgenic mice].
Baturin DA; Alimova IN; Popovich IG; Zabezhinskiĭ MA; Semenchenko AV; Iashin AI; Anisimov VN
Vopr Onkol; 2004; 50(3):332-8. PubMed ID: 15318708
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effect of the peptide epitalon on the development of spontaneous mammary tumors in HER-2/neu transgenic mice.
Anisimov VN; Khavinson VK; Provinciali M; Alimova IN; Baturin DA; Popovich IG; Zabezhinski MA; Imyanitov EN; Mancini R; Franceschi C
Int J Cancer; 2002 Sep; 101(1):7-10. PubMed ID: 12209581
[TBL] [Abstract][Full Text] [Related]
11. Metformin decelerates aging and development of mammary tumors in HER-2/neu transgenic mice.
Anisimov VN; Egormin PA; Bershtein LM; Zabezhinskii MA; Piskunova TS; Popovich IG; Semenchenko AV
Bull Exp Biol Med; 2005 Jun; 139(6):721-3. PubMed ID: 16224592
[TBL] [Abstract][Full Text] [Related]
12. [Age dynamics of angiogenesis markers in transgenic HER-2/neu (FBV/N) mammary adenocarcinoma-prone mice].
Trashkov AP; Panchenko AV; Korablev RV; Yurova MN; Egormin PA; Chernenko NA; Popovich IG; Tyndyk ML; Artemenko MR; Verlov NA; Vasiliev AG; Anisimov VN
Vopr Onkol; 2015; 61(4):642-6. PubMed ID: 26571837
[TBL] [Abstract][Full Text] [Related]
13. The effect of melatonin treatment regimen on mammary adenocarcinoma development in HER-2/neu transgenic mice.
Anisimov VN; Alimova IN; Baturin DA; Popovich IG; Zabezhinski MA; Manton KG; Semenchenko AV; Yashin AI
Int J Cancer; 2003 Jan; 103(3):300-5. PubMed ID: 12471612
[TBL] [Abstract][Full Text] [Related]
14. Insulin in aging and cancer: antidiabetic drug Diabenol as geroprotector and anticarcinogen.
Popovich IG; Zabezhinski MA; Egormin PA; Tyndyk ML; Anikin IV; Spasov AA; Semenchenko AV; Yashin AI; Anisimov VN
Int J Biochem Cell Biol; 2005 May; 37(5):1117-29. PubMed ID: 15743682
[TBL] [Abstract][Full Text] [Related]
15. Analysis of mammary carcinoma onset and progression in HER-2/neu oncogene transgenic mice reveals a lobular origin.
Di Carlo E; Diodoro MG; Boggio K; Modesti A; Modesti M; Nanni P; Forni G; Musiani P
Lab Invest; 1999 Oct; 79(10):1261-9. PubMed ID: 10532589
[TBL] [Abstract][Full Text] [Related]
16. Epithalon inhibits tumor growth and expression of HER-2/neu oncogene in breast tumors in transgenic mice characterized by accelerated aging.
Anisimov VN; Khavinsov VKh; Alimova IN; Provintsiali M; Manchini R; Francheski K
Bull Exp Biol Med; 2002 Feb; 133(2):167-70. PubMed ID: 12428286
[TBL] [Abstract][Full Text] [Related]
17. Ability of systemic interleukin-12 to hamper progressive stages of mammary carcinogenesis in HER2/neu transgenic mice.
Boggio K; Di Carlo E; Rovero S; Cavallo F; Quaglino E; Lollini PL; Nanni P; Nicoletti G; Wolf S; Musiani P; Forni G
Cancer Res; 2000 Jan; 60(2):359-64. PubMed ID: 10667588
[TBL] [Abstract][Full Text] [Related]
18. The collaboration of both humoral and cellular HER-2/neu-targeted immune responses is required for the complete eradication of HER-2/neu-expressing tumors.
Reilly RT; Machiels JP; Emens LA; Ercolini AM; Okoye FI; Lei RY; Weintraub D; Jaffee EM
Cancer Res; 2001 Feb; 61(3):880-3. PubMed ID: 11221874
[TBL] [Abstract][Full Text] [Related]
19. Analysis of HER-2/neu Receptor Expression and the Level of Neuronal Apoptosis in HER-2/neu Transgenic Mice during Aging.
Solovyova AS; Sokolova YO; Anisimov VN; Bazhanova ED
Bull Exp Biol Med; 2019 Aug; 167(4):512-515. PubMed ID: 31494768
[TBL] [Abstract][Full Text] [Related]
20. [Effect of Epitalon and Vilon treatment on mammary carcinogenesis in transgenic erbB-2/NEU mice].
Alimova IN; Bashurin DA; Popovich IG; Zabezhinskiĭ MA; Volkov MA; Provinciali M; Franceschi C; Khavincon BKh; Anisimov VN
Vopr Onkol; 2002; 48(1):57-60. PubMed ID: 12101568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
